Innovations in the Diagnosis and Treatment of Inflammatory Bowel Disease
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 3
Special Issue Editor
Interests: inflammatory bowel disease; metabolites of the gut microbiota; metabolic syndrome; metabolomics; obesity; liver disease; fatty acids; nutrition; inflammation
Special Issue Information
Dear Colleagues,
This Special Issue aims to bring together the latest research, clinical advances, and innovative approaches in the field of inflammatory bowel disease (IBD). We welcome high-quality original research and review articles that explore novel diagnostic tools, therapeutic strategies, and personalized medicine approaches in IBD management.
Key topics of interest include, but are not limited to, the following:
- Advances in molecular and imaging diagnostics for IBD;
- Emerging pharmacological and biological therapies;
- Personalized treatment approaches and precision medicine;
- Insights into pathophysiology and disease mechanisms;
- Quality of life and patient-centered outcomes.
We encourage researchers, clinicians, and healthcare professionals working in gastroenterology, immunology, and related fields to submit their manuscripts for consideration. This is an excellent opportunity to share your work with an international audience and contribute to the advancement of IBD research and clinical practice. We look forward to your valuable contributions and to showcasing cutting-edge innovations in the diagnosis and treatment of IBD.
Dr. Aldona Wierzbicka-Rucinska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease (IBD)
- molecular and imaging diagnostics
- personalized treatment approaches
- precision medicine
- pharmacological and biologic therapies
- pathophysiology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
